Serkan Yaraş

6PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersLiquid biopsiesPacific Peoples biomedical and clinical scienceCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 27, 2025
Upadacitinib in Biologic-Experienced Inflammatory Bowel Disease: Real-World Efficacy, Safety, and Laboratory Outcomes.

Osman Özdoğan, Serkan Yaraş

|Jan 18, 2025
Circulating chemokine levels and receptor polymorphisms have potential as biomarkers for fibrosis stages in patients with chronic hepatitis C infection.

Seren Oğultekin Teneke, Mehmet Sami Serin, Zehra Öksüz

|May 07, 2022
hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection.

Zehra Öksüz, Enver Üçbilek, Mehmet Sami Serin

|Nov 24, 2021
Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients.

Zehra Öksüz, Enver Üçbilek, Mehmet Sami Serin

|Mar 02, 2021
Pancreatic Steatosis Is Associated with Both Metabolic Syndrome and Pancreatic Stiffness Detected by Ultrasound Elastography.

Orhan Sezgin, Serkan Yaraş, Osman Özdoğan

|Sep 22, 2020
Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.

Zehra Öksüz, Enver Üçbilek, Mehmet Sami Serin

Pageof 1

Frequent Collaborators

4 joint publications

Zehra Öksüz

4 joint publications

Enver Üçbilek

4 joint publications

Mehmet Sami Serin

4 joint publications

Gülhan Orekici Temel